Get the app!
Back to Companies

SELLAS Life Sciences Group, Inc.

SLSNasdaqCIK: 0001390478

Over the 11 most recent insider filings, SELLAS Life Sciences Group, Inc. (SLS) has seen activity from 7 distinct insiders — 1 buying and 3 selling. The activity is heavily weighted toward selling: $100.8K bought versus $716.7K sold, net sales of $615.9K. Stergiou Angelos M. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $510.2K by Stergiou Angelos M.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$1.2M
Purchases
$100.8K
Sales
$716.7K
Unique Insiders
7

Recent Insider Trades

11 loaded
Nov 20SLS
SELLAS Life Sciences Group, Inc.
CICIC DRAGANSVP, Chief Development OfficerSell$133.0K
Nov 20SLS
SELLAS Life Sciences Group, Inc.
Stergiou Angelos M.President and CEO, DirectorSell$510.2K
Nov 20SLS
SELLAS Life Sciences Group, Inc.
Burns John ThomasCFOSell$73.5K
Jun 18SLS
SELLAS Life Sciences Group, Inc.
Stergiou Angelos M.President and CEO, DirectorGrant$0
Jan 9SLS
SELLAS Life Sciences Group, Inc.
CICIC DRAGANSVP, Chief Development OfficerGrant$0
Jan 9SLS
SELLAS Life Sciences Group, Inc.
VAN NOSTRAND ROBERT LDirectorGrant$0
Jan 9SLS
SELLAS Life Sciences Group, Inc.
Varian JohnDirectorGrant$0
Jan 9SLS
SELLAS Life Sciences Group, Inc.
SCHEINBERG DAVID ADirectorGrant$0
Dec 5SLS
SELLAS Life Sciences Group, Inc.
CICIC DRAGANSVP, Chief Development OfficerOther$95.7K
Dec 5SLS
SELLAS Life Sciences Group, Inc.
Stergiou Angelos M.President and CEO, DirectorOther$280.6K
Nov 21SLS
SELLAS Life Sciences Group, Inc.
Kalin Katherine BachDirectorBuy$100.8K

11 filings